Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the effect of graphene oxide in chitosan/alginate-based foams on the release and antifungal activity of clotrimazole in vitro.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2022
Same author

Graphene oxide as a functional excipient in buccal films for delivery of clotrimazole: Effect of molecular interactions on drug release and antifungal activity in vitro.

International journal of pharmaceutics·2020
Same author

Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome.

Oral diseases·2015
Same author

Development of a general analysis and unfolding scheme and its application to measure the energy spectrum of atmospheric neutrinos with IceCube: IceCube Collaboration.

The European physical journal. C, Particles and fields·2015
Same author

Flavor Ratio of Astrophysical Neutrinos above 35 TeV in IceCube.

Physical review letters·2015
Same author

Observation of high-energy astrophysical neutrinos in three years of IceCube data.

Physical review letters·2014

Related Experiment Video

Updated: Jun 21, 2026

Consistent Delivery of Adeno-Associated Virus via Lateral Tail-Vein Injection in Adult Mice
05:03

Consistent Delivery of Adeno-Associated Virus via Lateral Tail-Vein Injection in Adult Mice

Published on: August 23, 2024

Targeting ADAM12 in human disease: head, body or tail?

J Jacobsen1, U M Wewer

  • 1Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Current Pharmaceutical Design
|July 16, 2009
PubMed
Summary

ADAM12 (meltrin alpha) is a protein implicated in tumor progression and osteoarthritis. Understanding its complex roles is crucial for developing targeted therapies while managing potential side effects.

More Related Videos

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Related Experiment Videos

Last Updated: Jun 21, 2026

Consistent Delivery of Adeno-Associated Virus via Lateral Tail-Vein Injection in Adult Mice
05:03

Consistent Delivery of Adeno-Associated Virus via Lateral Tail-Vein Injection in Adult Mice

Published on: August 23, 2024

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathology

Background:

  • ADAM12 (meltrin alpha) is a type I transmembrane protein with roles in disease.
  • It possesses protease, cell binding, and cell signaling functions.
  • Its structure includes head, body, and tail domains, each with distinct biological activities.

Purpose of the Study:

  • To review the biology of ADAM12.
  • To explore its association with various diseases.
  • To evaluate therapeutic targeting strategies for ADAM12 in human diseases.

Main Methods:

  • Literature review of studies on ADAM12.
  • Analysis of ADAM12 structure-function relationships.
  • Evaluation of ADAM12's role in disease pathogenesis and progression.

Main Results:

  • ADAM12's head domain mediates growth factor processing and signaling.
  • The body domain facilitates interactions with the extracellular matrix and cell surface receptors.
  • The tail domain engages in intracellular signaling pathways.

Conclusions:

  • ADAM12 overexpression is linked to disease progression, particularly in cancer.
  • Both pro- and anti-disease effects of ADAM12 have been reported.
  • Further research is needed to elucidate ADAM12 mechanisms for safe therapeutic targeting.